Clinical Trials Logo

Abortion Early clinical trials

View clinical trials related to Abortion Early.

Filter by:
  • None
  • Page 1

NCT ID: NCT03320057 Not yet recruiting - Pregnancy Related Clinical Trials

Medication Abortion Via Pharmacy Dispensing

Start date: November 2017
Phase: Phase 4
Study type: Interventional

This mixed-methods study follows a prospective cohort of patients receiving Mifeprex ® (mifepristone) for medication abortion dispensed by pharmacists after undergoing standard clinical evaluation. Women participating in this study will obtain mifepristone and misoprostol from the pharmacy instead of in the clinic. To assess feasibility, acceptability, and effectiveness of pharmacy dispensing of mifepristone, the study will survey patients, evaluate their clinical outcomes from electronic health records, and survey and interview pharmacists at study sites.

NCT ID: NCT03047551 Recruiting - Abortion Early Clinical Trials

Transabdominal and Transvaginal Sonography in Medical Abortion

TASvTVS
Start date: July 2016
Phase: N/A
Study type: Interventional

The investigator will perform a multicenter, randomized controlled trial in practices that routinely use transvaginal sonography (TVS) to compare how often clinicians order additional testing prior to medical abortion after the use of either TVS or transabdominal ultrasound (TAS) in medical abortion eligibility assessment. Women will be randomized to receive either TVS or TAS prior to medical abortion. We anticipate enrolling 800 patients receiving care from about 30 providers over 6-8 months. The primary study outcome will be the proportion of women that requires additional evaluation after sonography, prior to determination of medical abortion eligibility. The second primary outcome will be patient satisfaction, determined by a patient satisfaction questionnaire utilizing a visual analog scale.

NCT ID: NCT02522078 Completed - Abortion Early Clinical Trials

Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion

MisoWet
Start date: August 2015
Phase: Phase 4
Study type: Interventional

This study aims to verify whether the moisture of 400 µg of misoprostol pre uterine evacuation increases the dilatation of uterine cervix compared to dry misoprostol